
How to create “humble” AI
An MIT-led team is designing artificial intelligence systems for medical diagnosis that are more collaborative and forthcoming about uncertainty.

An MIT-led team is designing artificial intelligence systems for medical diagnosis that are more collaborative and forthcoming about uncertainty.

MOUNTAIN LAKES, N.J., March 24, 2026 /PRNewswire/ — LiviWell, a women’s health company dedicated to developing innovative solutions for intimate health, today announced that the U.S. Food and Drug Administration (FDA) has cleared Livi, a first-of-its-kind device designed to support vaginal health by absorbing semen and other post-intercourse fluids.

The findings help explain why some people appear far more likely than others to transmit respiratory viruses and offer new insight into how influenza spreads through the air.

Researchers at Ouachita Baptist University are creating stitches loaded with anti-inflammatory drugs to deliver the medication directly to the injury.

By simplifying complex cardiac anatomy through real-time AI labeling, T-Mode™ Heart removes the training barrier to ultrasound adoption for family physicians and medical students.

Built for high reliability, world’s only lumenless defibrillation lead approved for placement in the left bundle branch area

This breakthrough could lead to next-generation medical tools that track disease, guide treatment and monitor the body in real time

The method relies on the fact that deuterium, once in the body, participates in biochemical reactions alongside ordinary hydrogen and becomes incorporated into the carbon-hydrogen bonds of organic compounds.

Chinese researchers have developed a novel and highly efficient mitochondrial capsule transplantation therapy.

Powerful brain imaging has helped uncover why people with post-traumatic stress disorder (PTSD) who engage in negative self-talk may be struggling with the first line of treatment. The discovery, published in Nature Mental Health, sheds new light as to why underlying brain mechanisms mean some therapies potentially work for some people and not others, and could guide the development of more targeted treatments for PTSD.